We use science-based innovation to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to provide a shareholder return that rewards those who invest their money, time and ideas in our company.
Novartis is committed to refining, reducing and replacing animals in research and to upholding the highest standards in animal welfare. We have a Global Animal Welfare Organization that is dedicated to ensuring the animal’s well-being.
|Channel:||Website - E-mail - Audio / Video - Social media - Professional online network|
|Relevance:||Replacement - Reduction - Refinement|
|Purpose:||Fundamental studies - Toxicological and safety evaluation - Production and quality control - Efficacy testing - Regulatory testing - Animal welfare|
|Legislative framework:||Medicines legislation|
|Technology/Tools:||Alternative test methods (in vitro) - Non-testing methods (in silico) - Animal testing (in vivo)|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.